MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 74 filers reported holding MEREO BIOPHARMA GROUP PLC in Q4 2021. The put-call ratio across all filers is 4.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,927 | -34.2% | 26,300 | -32.7% | 0.00% | 0.0% |
| Q2 2023 | $51,562 | +232.1% | 39,062 | +77.9% | 0.00% | – |
| Q1 2023 | $15,525 | -8.7% | 21,962 | +13.4% | 0.00% | -100.0% |
| Q3 2022 | $17,000 | -67.3% | 19,362 | -58.5% | 0.00% | -50.0% |
| Q2 2022 | $52,000 | +6.1% | 46,695 | +5.9% | 0.00% | 0.0% |
| Q1 2022 | $49,000 | -30.0% | 44,095 | +0.7% | 0.00% | 0.0% |
| Q4 2021 | $70,000 | -19.5% | 43,773 | +21.4% | 0.00% | -33.3% |
| Q3 2021 | $87,000 | +112.2% | 36,043 | +177.3% | 0.00% | +50.0% |
| Q2 2021 | $41,000 | – | 13,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,220,938 | $16,299,000 | 0.94% |
| Boxer Capital, LLC | 4,029,649 | $10,558,000 | 0.36% |
| DAFNA Capital Management LLC | 199,425 | $522,000 | 0.17% |
| J. Goldman & Co LP | 443,517 | $1,162,000 | 0.08% |
| Ikarian Capital, LLC | 1,196,308 | $688,000 | 0.05% |
| HHLR ADVISORS, LTD. | 1,598,185 | $4,187,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 133,634 | $350,000 | 0.02% |
| F3Logic, LLC | 255 | $668,000 | 0.02% |
| Schonfeld Strategic Advisors LLC | 343,195 | $899,000 | 0.02% |
| CSS LLC/IL | 54,773 | $144,000 | 0.01% |